Regulatorische Updates
12. Sept. 2026•3 Min. Lesezeit
South Korea widens insurance coverage for rare disease, cancer drugs
South Korea’s Ministry of Health and Welfare announced faster reimbursement for Dravet syndrome treatment Fintepla‑Ac and broader coverage for blood‑cancer and pediatric‑leukemia drugs.
Regulatorische Updates
27. Aug. 2026•3 Min. Lesezeit
FDA Approves Orca Bio’s Allogeneic Treg Cell Therapy Tregzi for Blood Cancer Transplants
Orca Bio received FDA approval for Tregzi, an allogeneic regulatory T‑cell therapy for blood‑cancer patients needing transplants.